Forensic Analysis · Pharmaceuticals & Biotechnology · as of Nov 8, 2026

Schrodinger, Inc. (SDGR)

A forensic read on Schrodinger, Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.

D · Weak — demands caution

Forensic grade

Distress

Financial health

-0.3

Distress distance

Clean

Earnings quality

Forensic signals

-26.3%

ROE

23.3%

Revenue growth

This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (auditor quality, say on pay, board independence, going concern). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.

Schrodinger, Inc. earns a D (Weak — demands caution) forensic quality grade, and its balance-sheet distress test reads -0.3, placing it in the Distress zone. 2 forensic signals were flagged in its latest SEC filings, led by return on invested capital.

What the filings flag

-33.4%

FY2025

Return on invested capital. Return on invested capital is -33.4% in the latest fiscal year and slipping across FY2023–FY2025 from -31.1%. After-tax operating profit was ($160M) in FY2023 and ($132M) in FY2025, with operating income at -81.9% of revenue in FY2023, -100.8% in FY2024 and -65.2% in FY2025. The capital base behind it came down -23% across FY2023–FY2025, from $514M to $395M, so this return is struck on a smaller base than it started on. $185M of the $395M base at FY2025 is short-term investments (46.8%) — securities held beside cash, which the base keeps because only cash is subtracted from it; they earn the balance sheet's yield, which is not in the operating profit above, so the loss on the operating capital is larger than this rate shows.

-$280.2M

FY2023–FY2025

Cash burn vs. reported loss. Over FY2023–FY2025, the company reported a cumulative net loss of $249.7M against operating cash flow of -$280.2M. Cash burn ran heavier than the reported loss — something outside net income (working capital, a cash item not in the P&L) is consuming cash faster than the loss alone implies.

Key fundamentals

Latest Revenue$255.9M

Revenue Growth YoY+23.3%

Revenue CAGR (2yr)+8.7%

Net Margin-40.4%

Free Cash Flow$12.5M

Return on Equity-26.3%

The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Schrodinger, Inc.'s actual 10-K/10-Q/8-K filings?

Generate the AI investment read →

No credit card · informational only, not investment advice · see the track record

← Browse all forensic stock analyses

Data from SEC EDGAR public filings · metrics as of Nov 8, 2026. Forensic signals flag probability, not certainty.

See a wrong number? Report an error with the filing it should match.